Screener
ANI Pharmaceuticals ANIP Current Debt
Current Debt at other companies
Other financials
Where this comes from
Reported directly by ANI Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:LongTermDebtCurrent.
The source filing: ANI Pharmaceuticals’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 7, 2026, 7:01 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001023024-26-000069
FAQ
- What is ANI Pharmaceuticals's current debt?
- ANI Pharmaceuticals (ANIP) reported current debt of $21.33M in Q2 2026.
- How has ANI Pharmaceuticals's current debt changed year-over-year?
- ANI Pharmaceuticals's current debt increased by 61.4% year-over-year, from $13.22M to $21.33M.
- What is the long-term trend for ANI Pharmaceuticals's current debt?
- Over 5 years (2020 to 2025), ANI Pharmaceuticals's current debt has grown at a 5.5% compound annual growth rate (CAGR), from $13.24M to $17.27M.
- What does current debt mean?
- The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.
Ask your AI about ANI Pharmaceuticals's current debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude